Jazz Pharmaceuticals plc — Director's Dealing 2019

Feb 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2019-02-25

Reporting Person: Young Matthew P. (EVP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-25	Ordinary Shares	F	1218	$126.25	Disposed	30917	Direct
2019-02-26	Ordinary Shares	S	1032	$125.93	Disposed	29885	Direct
2019-02-26	Ordinary Shares	F	1034	$127.76	Disposed	28851	Direct
2019-02-27	Ordinary Shares	S	884	$137.91	Disposed	27967	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

F2: Includes 67 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2018.

F3: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.